| 产品详情 |
| Edit |   |
| Product Name | 15(S)-HETE Ethanolamide |
| Description | Purity >98%. Arachidonoyl ethanolamide (AEA) was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2 ) as THC. Since that time, a number of related endocannabinoids have been isolated, most notably 2-arachidonoyl glycerol . Lipoxygenases, especially rabbit reticulocyte and soybean 15-lipoxygenases, actively convert endocannabinoids to their 15(S)-hydroperoxy and hydroxy metabolites. 15(S)-HETE ethanolamide is less potent than AEA at the CB1 receptor (Ki of 600 versus 90 nM). 15(S)-HETE ethanolamide also inhibits fatty acid amide hydrolase. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 15(S)-hydroxy-N-(2-hydroxyethyl)-5Z,8Z,11Z,13E-eicosatetraenamide, 15(S)-HAEA |
| Gene, Accession, CAS # | CAS: 161744-53-2 |
| Catalog # | LS-H5842 |
| Price | |
| Order / More Info | 15(S)-HETE Ethanolamide from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|